Nevertheless, it appears that in contrast to GSIs, the ability of NRR antibodies to inhibit growth is likely to be limited to T-ALL lines bearing class I Notch1 mutations, as receptors harboring unusual juxtamembrane insertional mutations [35], [58] were completely resistant to the inhibition by NRR antibodies. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.